Erratum: Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression (Clinical Breast Cancer 12:3 DOI: 10.1016/j.clbc.2012.03.006);Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression

Clinical Breast Cancer

Volumn 12, Issue 3, 2012, Pages 183-193

  Razis, Evangelia ^a   Kalogeras, Konstantine T ^b   Kotoula, Vassiliki ^c   Eleftheraki, Anastasia G ^b   Nikitas, Nikitas ^d   Kronenwett, Ralf ^e   Timotheadou, Eleni ^c   Christodoulou, Christos ^f   Pectasides, Dimitrios ^g   Gogas, Helen ^h   Wirtz, Ralph M ^e   Makatsoris, Thomas ⁱ   Bafaloukos, Dimitrios ^f   Aravantinos, Gerasimos ^j   Televantou, Despina ^c   Pavlidis, Nicholas ^k   Fountzilas, George ^c  

^a HYGEIA HOSPITAL   (Greece)

^b Hellenic Cooperative Oncology Group   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e SIEMENS AG   (Germany)

^f METROPOLITAN HOSPITAL   (Greece)

^g HIPPOKRATION HOSPITAL   (Greece)

^h UNIVERSITY OF ATHENS   (Greece)

ⁱ UNIVERSITY OF PATRAS   (Greece)

^j AGII ANARGIRI CANCER HOSPITAL   (Greece)

^k UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

more..

Author keywords

Chemokines; CXCL12; CXCL13; CXCR5; Estrogen receptor; Human epidermal growth factor receptor 2; Progesterone receptor

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; FORMALDEHYDE; GRANULOCYTE COLONY STIMULATING FACTOR; MESSENGER RNA; METHOTREXATE; PACLITAXEL; PARAFFIN; PROGESTERONE RECEPTOR; TAU PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HAZARD RATIO; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN MOTIF; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TISSUE FIXATION; TUMOR ASSOCIATED LEUKOCYTE;

EID: 84861111629     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2012.08.001     Document Type: Erratum

References (23)

1. A.D. Luster Chemokines: chemotactic cytokines that mediate inflammation N Engl J Med 338 1998 436 445
2. L.A. Liotta An attractive force in metastasis Nature 410 2001 24 25
3. A. Müller, B. Homey, H. Soto Involvement of chemokine receptors in breast cancer metastasis Nature 410 2001 50 56
4. P.M. Murphy Chemokines and the molecular basis of cancer metastasis N Engl J Med 345 2001 833 835
5. R. Horuk Chemokine receptor antagonists: overcoming developmental hurdles Nat Rev Drug Discov 8 2009 23 33
6. J. Panse, K. Friedrichs, A. Marx Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients Br J Cancer 99 2008 930 938
7. L.Y. Feng, Z.L. Ou, F.Y. Wu Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival Clin Cancer Res 15 2009 2962 2970
8. G. Fountzilas, D. Skarlos, U. Dafni Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group Ann Oncol 16 2005 1762 1771
9. G. Pentheroudakis, A. Batistatou, K.T. Kalogeras Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study Breast Cancer Res Treat 127 2011 179 193
10. K. Bohmann, G. Hennig, U. Rogel RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods Clin Chem 55 2009 1719 1727
11. B.M. Müller, R. Kronenwett, G. Hennig Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue: a new option for predictive biomarker assessment in breast cancer Diagn Mol Pathol 20 2011 1 10
12. C.A. Hudis, W.E. Barlow, J.P. Costantino Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system J Clin Oncol 25 2007 2127 2132
13. L.M. McShane, D.G. Altman, W. Sauerbrei Reporting recommendations for tumor marker prognostic studies J Clin Oncol 23 2005 9067 9072
14. R.M. Simon, S. Paik, D.F. Hayes Use of archived specimens in evaluation of prognostic and predictive biomarkers J Natl Cancer Inst 101 2009 1446 1452
15. M.D. Gunn, V.N. Ngo, K.M. Ansel A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 Nature 391 1998 799 803
16. G. Aust, D. Sittig, L. Becherer The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases Eur J Endocrinol 150 2004 225 234
17. C. Dell'Agnola, A. Biragyn Clinical utilization of chemokines to combat cancer: the double-edged sword Expert Rev Vaccines 6 2007 267 283
18. S. Ali, G. Lazennec Chemokines: novel targets for breast cancer metastasis Cancer Metastasis Rev 26 2007 401 420
19. R.J. Epstein The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies Nat Rev 4 2004 1 9
20. J.D. Shields, I.C. Kourtis, A.A. Tomei Induction of lymphoid like stroma and immune escape by tumors that express the chemokine CCL21 Science 328 2010 749 752
21. C. Yau, L. Esserman, D.H. Moore A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple negative breast cancer Breast Cancer Res 12 2010 R85
22. D.G. Duda, S.V. Kozin, N.D. Kirkpatrick CXCL12 (SDF1α)-CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies Clin Cancer Res 17 2011 2074 2080
23. J.H. Chu, R. Lazarus, V.J. Carey Quantifying differential gene connectivity between disease states for objective identification of disease relevant genes BMC Syst Biol 5 2011 89